Retinal Degeneration Clinical Trials

67 clinical trials for Retinal Degeneration across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Cell Collection to Study Eye Diseases — RECRUITING
• Rod and Cone Mediated Function in Retinal Disease — RECRUITING
• First-in-Human, Dose Escalation Trial of AXV-101 in BBS1-Related Retinal Degeneration — RECRUITING · PHASE1
• A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO) — RECRUITING · PHASE1
• Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab — RECRUITING
• Adaptive Optics Imaging of Outer Retinal Diseases — RECRUITING
• SGLT2 Inhibitors in Geographic Atrophy — RECRUITING · PHASE2
• High Resolution, High-speed Multimodal Ophthalmic Imaging — RECRUITING · NA
• A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema — RECRUITING · PHASE3
• A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection — RECRUITING
• Minocycline for Chronic Autoimmune Uveitis — RECRUITING · PHASE1
• Oral Metformin for Treatment of ABCA4 Retinopathy — ACTIVE_NOT_RECRUITING · PHASE1
• Natural History of Eye Diseases Related to ABCA4 Mutations — ACTIVE_NOT_RECRUITING
• MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby) — COMPLETED · PHASE1
• A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001 — ACTIVE_NOT_RECRUITING · PHASE1
• Multicenter Study of Transcranial Magnetic Stimulation on Vision Restoration — NOT_YET_RECRUITING · NA
• Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F — ACTIVE_NOT_RECRUITING
• FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD — TERMINATED · PHASE1
• Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE) — COMPLETED · PHASE2
• Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study — ACTIVE_NOT_RECRUITING
• Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis — ACTIVE_NOT_RECRUITING · PHASE1
• Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study — ACTIVE_NOT_RECRUITING
• BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases — COMPLETED · NA
• GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) — TERMINATED
• Performance of Long-wavelength Autofluorescence Imaging — COMPLETED · NA
• Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE] — COMPLETED · PHASE2
• Validation of Questionnaire in Retinal Degeneration — OTHER · NA
• NR600 System Retinal Prosthesis for Patients With Retinal Degenerative Diseases — TERMINATED · NA
• Pistachios and Neural Macular Pigment — OTHER · NA
• Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration — COMPLETED · PHASE3
• Single Ascending Dose Study in Participants With LCA10 — OTHER · PHASE1
• A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration — TERMINATED · PHASE2
• A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration — TERMINATED · PHASE2
• Natural History Study of CEP290-Related Retinal Degeneration — COMPLETED
• Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy — COMPLETED · PHASE1
• Dual Wavelength OCT — COMPLETED
• An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene. — OTHER · PHASE2
• X-82 to Treat Age-related Macular Degeneration — TERMINATED · PHASE2
• Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa — COMPLETED · PHASE1
• The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients — OTHER · PHASE1
• First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration — COMPLETED · PHASE1
• Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD — COMPLETED · PHASE3
• Bimodal and Coaxial High Resolution Ophtalmic Imaging — OTHER · NA
• Assessment of Visual Function With a Portable Brain-computer Interface — OTHER
• High Resolution Retina Imaging — OTHER
• Evaluation of Discomfort Associated With Scleral Depression During Retina Examinations — COMPLETED · NA
• Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification — COMPLETED · NA
• Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma. — COMPLETED · PHASE1
• Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS — TERMINATED · NA
• Stem Cells Therapy in Degenerative Diseases of the Retina — OTHER · PHASE1

Refine this search